Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
1.235 USD | +3.78% | +7.02% | -33.70% |
Nov. 08 | Transcript : P3 Health Partners Inc., Q3 2023 Earnings Call, Nov 08, 2023 | CI |
Nov. 08 | Earnings Flash (PIII) P3 HEALTH PARTNERS Posts Q3 Revenue $288.4M, vs. Street Est of $293.3M | MT |
Financials (USD)
Sales 2023 * | 1,222 M | Sales 2024 * | 1,415 M | Capitalization | 137 M |
---|---|---|---|---|---|
Net income 2023 * | -74.00 M | Net income 2024 * | -45.00 M | EV / Sales 2023 * | 0,18x |
Net Debt 2023 * | 87.40 M | Net Debt 2024 * | 79.00 M | EV / Sales 2024 * | 0,15x |
P/E ratio 2023 * | -1,95x | P/E ratio 2024 * | -3,61x | Employees | 600 |
Yield 2023 * | - | Yield 2024 * | - | Free-Float | 74.42% |
More Fundamentals
* Assessed data
More news
More press releases
1 day | +3.78% | ||
1 week | +7.02% | ||
Current month | -14.69% | ||
1 month | -14.69% | ||
3 months | -13.48% | ||
6 months | -71.09% | ||
Current year | -33.70% |
1 week
1.10
1.25

1 month
1.10
1.58

Current year
0.70
5.56

1 year
0.70
5.56

3 years
0.70
16.73

5 years
0.70
16.73

10 years
0.70
16.73

Managers | Title | Age | Since |
---|---|---|---|
Sherif Abdou
FOU | Founder | 62 | 2020 |
Amir Bacchus
FOU | Founder | 59 | 2020 |
Atul Kavthekar
DFI | Director of Finance/CFO | 55 | Dec. 11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Tolan
BRD | Director/Board Member | 62 | 2021 |
Gregory Wasson
BRD | Director/Board Member | 64 | 2021 |
Mark Thierer
CHM | Chairman | 63 | 2021 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 678 M€ | -7.13% | ||
0.01% | 620 M€ | +4.66% | - | |
0.01% | 8,183 M€ | +4.31% |
Date | Price | Change | Volume |
---|---|---|---|
23-11-28 | 1.225 | +2.94% | 232 929 |
23-11-27 | 1.190 | +1.71% | 156,214 |
23-11-24 | 1.170 | +2.63% | 46,204 |
23-11-22 | 1.140 | 0.00% | 111,144 |
23-11-21 | 1.140 | -4.20% | 263,065 |
Delayed Quote Nasdaq, November 28, 2023 at 02:30 pm EST
More quotes
P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company transforms healthcare by improving the lives of both patients and providers led by physicians. The Company has an expansive network of approximately 2,800 affiliated primary care providers across the country. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, the Company creates an enhanced patient experience by navigating, coordinating, and integrating the patient's care within the healthcare system. The Company serves Arizona, Nevada, Florida, Oregon, California, and more. The Company offers P3 care model that consists of education, tools, and support to manage illness, prevention and wellness support, medication management, nursing support, access to community resources and services, and transition of care teams.
Calendar
2024-04-21
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy

Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.190USD
Average target price
5.833USD
Spread / Average Target
+390.20%
EPS Revisions
1st Jan change | Capi. (M$) | |
---|---|---|
-33.70% | 137 M $ | |
+66.77% | 40 453 M $ | |
+3.47% | 38 458 M $ | |
-56.93% | 29 633 M $ | |
-25.18% | 29 066 M $ | |
+38.67% | 22 180 M $ | |
-32.16% | 19 978 M $ | |
+2.80% | 17 370 M $ | |
-17.48% | 10 860 M $ | |
-10.51% | 9 987 M $ |